AAAAAA

   
Results: 1-10 |
Results: 10
Re: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselectedFinnish breast cancer patients - Response
Authors: Vahteristo, P Syrjakoski, K Eerola, H Kainu, T Holli, K Blomqvist, C Kallioniemi, OP Nevanlinna, H
Citation: P. Vahteristo et al., Re: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselectedFinnish breast cancer patients - Response, J NAT CANC, 93(2), 2001, pp. 153-154
BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients
Authors: Sarantaus, L Vahteristo, P Bloom, E Tamminen, A Unkila-Kallio, L Butzow, R Nevanlinna, H
Citation: L. Sarantaus et al., BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients, EUR J HUM G, 9(6), 2001, pp. 424-430
Involvement of BRCA1 and BRCA2 in breast cancer in a Western Finnish sub-population
Authors: Paakkonen, K Sauramo, S Sarantaus, L Vahteristo, P Hartikainen, A Vehmanen, P Ignatius, J Ollikainen, V Kaariainen, H Vauramo, E Nevanlinna, H Krahe, R Holli, K Kere, J
Citation: K. Paakkonen et al., Involvement of BRCA1 and BRCA2 in breast cancer in a Western Finnish sub-population, GENET EPID, 20(2), 2001, pp. 239-246
Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breastcancer families: A relative survival analysis from Finland
Authors: Eerola, H Vahteristo, P Sarantaus, L Kyyronen, P Pyrhonen, S Blomqvist, C Pukkala, E Nevanlinna, H Sankila, R
Citation: H. Eerola et al., Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breastcancer families: A relative survival analysis from Finland, INT J CANC, 93(3), 2001, pp. 368-372
p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: Further evidence of CHK2 in inherited cancer predisposition
Authors: Vahteristo, P Tamminen, A Karvinen, P Eerola, H Eklund, C Aaltonen, LA Blomqvist, C Aittomaki, K Nevanlinna, H
Citation: P. Vahteristo et al., p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: Further evidence of CHK2 in inherited cancer predisposition, CANCER RES, 61(15), 2001, pp. 5718-5722
A probability model for predicting BRCA1 and BRCA2 mutations in breast andbreast-ovarian cancer families
Authors: Vahteristo, P Eerola, H Tamminen, A Blomqvist, C Nevanlinna, H
Citation: P. Vahteristo et al., A probability model for predicting BRCA1 and BRCA2 mutations in breast andbreast-ovarian cancer families, BR J CANC, 84(5), 2001, pp. 704-708
Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites
Authors: Rapakko, K Allinen, M Syrjakoski, K Vahteristo, P Huusko, P Vahakangas, K Eerola, H Kainu, T Kallioniemi, OP Nevanlinna, H Winqvist, R
Citation: K. Rapakko et al., Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites, BR J CANC, 84(1), 2001, pp. 116-119
Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients
Authors: Syrjakoski, K Vahteristo, P Eerola, H Tamminen, A Kivinummi, K Sarantaus, L Holli, K Blomqvist, C Kallioniemi, OP Kainu, T Nevanlinna, H
Citation: K. Syrjakoski et al., Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients, J NAT CANC, 92(18), 2000, pp. 1529-1531
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland
Authors: Sarantaus, L Huusko, P Eerola, H Launonen, V Vehmanen, P Rapakko, K Gillanders, E Syrjakoski, K Kainu, T Vahteristo, P Krahe, R Paakkonen, K Hartikainen, J Blomqvist, C Lopponen, T Holli, K Ryynanen, M Butzow, R Borg, A Arver, BW Holmberg, E Mannermaa, A Kere, J Kallioniemi, OP Winqvist, R Nevanlinna, H
Citation: L. Sarantaus et al., Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland, EUR J HUM G, 8(10), 2000, pp. 757-763
The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations
Authors: Mazoyer, S Leary, J Kirk, J Fleischmann, E Wagner, T Claes, K Messiaen, L Foulkes, W Desrochers, M Simard, J Phelan, CM Kwan, E Narod, SA Vahteristo, P Nevanlinna, H Durando, X Bignon, YJ Peyrat, JP Bonnardel, C Sinilnikova, OM Puget, N Lenoir, GM Mazoyer, S Audoynaud, C Goldgar, D Maugard, C Caux, V Gad, S Stoppa-Lyonnet, D Nogues, C Lidereau, R Machavoine, C Bressac-de Paillerets, B Kuschel, B Betz, B Niederacher, D Beckmann, MW Hamann, U Gayther, SA Ponder, BAP Robinson, M Taylor, GR Bishop, T Catteau, A Solomon, E Cohen, B Steel, M Collins, N Stratton, M van der Looij, M Olah, E Miller, NJ Barton, DE Sverdlov, RS Friedman, E Radice, P Montagna, M Sensi, E Caligo, M van Eijk, R Devilee, P van der Luijt, R Heimdal, K Moller, P Borg, A Diez, O Cortes, J Domenech, M Baiget, M Osorio, A Benitez, J Borg, A Maillet, P Sappino, AP Ozdag, H Ozcelik, T Ozturk, M Rohlfs, EM Boyd, J McDermott, D Offit, K Unger, M Nathanson, K Weber, BL Sellers, TA Hampton, E Couch, FJ Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212
Risultati: 1-10 |